Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,241 to 1,260 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Breast Cancer Treatments: Updates and New Challenges. | J Pers Med | 2021 | 34442452 | PubTator, text mining | PubMed |
| Structure, Activity and Function of the SETDB1 Protein Methyltransferase. | Life (Basel) | 2021 | 34440561 | PubTator, text mining | PubMed |
| Genes Common in Primary Immunodeficiencies and Cancer Display Overrepresentation of Codon CTG and Dominant Role of Selection Pressure in Shaping Codon Usage. | Biomedicines | 2021 | 34440205 | PubTator, text mining | PubMed |
| Reveals of candidate active ingredients in Justicia and its anti-thrombotic action of mechanism based on network pharmacology approach and experimental validation. | Sci Rep | 2021 | 34433871 | PubTator, text mining | PubMed |
| Hyperprogression under immunotherapy: a new form of immunotherapy response?-a narrative literature review. | Transl Lung Cancer Res | 2021 | 34430364 | PubTator, text mining | PubMed |
| Characterization of human FDCs reveals regulation of T cells and antigen presentation to B cells. | J Exp Med | 2021 | 34424268 | PubTator, text mining | PubMed |
| Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor Cytotoxicity. | Front Immunol | 2021 | 34413859 | PubTator, text mining | PubMed |
| Immunological Involvement of MicroRNAs in the Key Events of Systemic Lupus Erythematosus. | Front Immunol | 2021 | 34408748 | PubTator, text mining | PubMed |
| Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy. | Cytotherapy | 2021 | 34404616 | PubTator, text mining | PubMed |
| Clinical profiles of SS-ILD compared with SS-NILD in a Chinese population: a retrospective analysis of 735 patients. | Ann Med | 2021 | 34402690 | PubTator, text mining | PubMed |
| Increased MMP12 mRNA expression in induced sputum was correlated with airway eosinophilic inflammation in asthma patients: Evidence from bioinformatic analysis and experiment verification. | Gene | 2021 | 34384863 | PubTator, text mining | PubMed |
| Lack of Interferon (IFN) Regulatory Factor 8 Associated with Restricted IFN-γ Response Augmented Japanese Encephalitis Virus Replication in the Mouse Brain. | J Virol | 2021 | 34379515 | PubTator, text mining | PubMed |
| Nutraceuticals in Viral Infections: An Overview of the Immunomodulating Properties. | Nutrients | 2021 | 34371920 | PubTator, text mining | PubMed |
| The Provocative Roles of Platelets in Liver Disease and Cancer. | Front Oncol | 2021 | 34367949 | PubTator, text mining | PubMed |
| The Role of Innate Immunity and Bioactive Lipid Mediators in COVID-19 and Influenza. | Front Physiol | 2021 | 34366882 | PubTator, text mining | PubMed |
| Tuning IgE: IgE-Associating Molecules and Their Effects on IgE-Dependent Mast Cell Reactions. | Cells | 2021 | 34359869 | PubTator, text mining | PubMed |
| Association of Immune and Inflammatory Gene Polymorphism With the Risk of IgA Nephropathy: A Systematic Review and Meta-Analysis of 45 Studies. | Front Immunol | 2021 | 34354705 | PubTator, text mining | PubMed |
| Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease. | Front Pediatr | 2021 | 34350146 | PubTator, text mining | PubMed |
| Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody. | Emerg Microbes Infect | 2021 | 34346827 | PubTator, text mining | PubMed |
| Immune environment of the brain in schizophrenia and during the psychotic episode: A human post-mortem study. | Brain Behav Immun | 2021 | 34339805 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=63